Global Medical REIT (NYSE:GMRE) Raised to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Global Medical REIT (NYSE:GMRE) from a strong sell rating to a hold rating in a research report released on Thursday, Zacks.com reports.

According to Zacks, “Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. “

Several other research firms have also recently weighed in on GMRE. Boenning Scattergood set a $21.00 price target on Essential Properties Realty Trust and gave the company a buy rating in a report on Friday, May 10th. Stifel Nicolaus began coverage on SkyWest in a report on Monday, April 15th. They issued a buy rating and a $68.00 price target on the stock. TheStreet cut Trade Desk from a b- rating to a c- rating in a report on Thursday, May 9th. Finally, ValuEngine cut Zumiez from a hold rating to a sell rating in a report on Tuesday, July 2nd. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Global Medical REIT presently has a consensus rating of Buy and an average price target of $10.67.

Shares of GMRE opened at $10.78 on Thursday. The business’s 50-day moving average is $10.78. The stock has a market cap of $361.91 million, a PE ratio of 13.82, a price-to-earnings-growth ratio of 1.56 and a beta of 0.42. The company has a debt-to-equity ratio of 0.76, a current ratio of 0.08 and a quick ratio of 0.08. Global Medical REIT has a 52-week low of $8.10 and a 52-week high of $11.51.

Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.18). The company had revenue of $15.20 million for the quarter, compared to analysts’ expectations of $15.32 million. Global Medical REIT had a return on equity of 5.52% and a net margin of 21.38%. As a group, research analysts predict that Global Medical REIT will post 0.77 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, July 11th. Shareholders of record on Wednesday, June 26th were issued a $0.20 dividend. The ex-dividend date of this dividend was Tuesday, June 25th. This represents a $0.80 annualized dividend and a dividend yield of 7.42%. Global Medical REIT’s payout ratio is currently 102.56%.

Large investors have recently added to or reduced their stakes in the business. Marshall Wace LLP bought a new position in shares of Global Medical REIT during the 1st quarter valued at about $6,569,000. Psagot Investment House Ltd. bought a new position in shares of Global Medical REIT during the 1st quarter valued at about $6,085,000. Nordea Investment Management AB bought a new position in shares of Global Medical REIT during the 1st quarter valued at about $1,434,000. ClariVest Asset Management LLC bought a new position in shares of Global Medical REIT during the 1st quarter valued at about $1,434,000. Finally, Marshall Wace North America L.P. bought a new position in shares of Global Medical REIT during the 1st quarter valued at about $1,111,000. 51.96% of the stock is currently owned by hedge funds and other institutional investors.

About Global Medical REIT

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Featured Article: Catch-Up Contributions

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.